272 related articles for article (PubMed ID: 26995734)
1. Partitioned log-rank tests for the overall homogeneity of hazard rate functions.
Liu Y; Yin G
Lifetime Data Anal; 2017 Jul; 23(3):400-425. PubMed ID: 26995734
[TBL] [Abstract][Full Text] [Related]
2. A sample size formula for the supremum log-rank statistic.
Eng KH; Kosorok MR
Biometrics; 2005 Mar; 61(1):86-91. PubMed ID: 15737081
[TBL] [Abstract][Full Text] [Related]
3. Ball divergence for the equality test of crossing survival curves.
You N; He X; Dai H; Wang X
Stat Med; 2023 Dec; 42(29):5353-5368. PubMed ID: 37752757
[TBL] [Abstract][Full Text] [Related]
4. Sequential tests for non-proportional hazards data.
Brückner M; Brannath W
Lifetime Data Anal; 2017 Jul; 23(3):339-352. PubMed ID: 26969674
[TBL] [Abstract][Full Text] [Related]
5. Two-sample tests for survival data from observational studies.
Li C
Lifetime Data Anal; 2018 Jul; 24(3):509-531. PubMed ID: 28849359
[TBL] [Abstract][Full Text] [Related]
6. Interim monitoring using the adaptively weighted log-rank test in clinical trials for survival outcomes.
Yang S
Stat Med; 2019 Feb; 38(4):601-612. PubMed ID: 30209818
[TBL] [Abstract][Full Text] [Related]
7. A win ratio approach for comparing crossing survival curves in clinical trials.
Zheng S; Wang D; Qiu J; Chen T; Gamalo M
J Biopharm Stat; 2023 Jul; 33(4):488-501. PubMed ID: 36749067
[TBL] [Abstract][Full Text] [Related]
8. Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology.
Horiguchi M; Hassett MJ; Uno H
Clin Trials; 2020 Dec; 17(6):597-606. PubMed ID: 32933339
[TBL] [Abstract][Full Text] [Related]
9. Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data.
Pepe MS; Fleming TR
Biometrics; 1989 Jun; 45(2):497-507. PubMed ID: 2765634
[TBL] [Abstract][Full Text] [Related]
10. Log-Rank Test vs MaxCombo and Difference in Restricted Mean Survival Time Tests for Comparing Survival Under Nonproportional Hazards in Immuno-oncology Trials: A Systematic Review and Meta-analysis.
Mukhopadhyay P; Ye J; Anderson KM; Roychoudhury S; Rubin EH; Halabi S; Chappell RJ
JAMA Oncol; 2022 Sep; 8(9):1294-1300. PubMed ID: 35862037
[TBL] [Abstract][Full Text] [Related]
11. Statistical inference methods for two crossing survival curves: a comparison of methods.
Li H; Han D; Hou Y; Chen H; Chen Z
PLoS One; 2015; 10(1):e0116774. PubMed ID: 25615624
[TBL] [Abstract][Full Text] [Related]
12. Comparing survival functions with interval-censored data in the presence of an intermediate clinical event.
Kim S; Kim J; Nam CM
BMC Med Res Methodol; 2018 Oct; 18(1):98. PubMed ID: 30285636
[TBL] [Abstract][Full Text] [Related]
13. A weighted log-rank test and associated effect estimator for cancer trials with delayed treatment effect.
Yu C; Huang X; Nian H; He P
Pharm Stat; 2021 May; 20(3):528-550. PubMed ID: 33427400
[TBL] [Abstract][Full Text] [Related]
14. A comparative study to alternatives to the log-rank test.
Dormuth I; Liu T; Xu J; Pauly M; Ditzhaus M
Contemp Clin Trials; 2023 May; 128():107165. PubMed ID: 36972865
[TBL] [Abstract][Full Text] [Related]
15. Comparison of methods to testing for differential treatment effect under non-proportional hazards data.
Pardo MDC; Cobo B
Math Biosci Eng; 2023 Sep; 20(10):17646-17660. PubMed ID: 38052530
[TBL] [Abstract][Full Text] [Related]
16. Quantifying treatment differences in confirmatory trials under non-proportional hazards.
Jiménez JL
J Appl Stat; 2022; 49(2):466-484. PubMed ID: 35707213
[TBL] [Abstract][Full Text] [Related]
17. A flexible approach to the crossing hazards problem.
Muggeo VM; Tagliavia M
Stat Med; 2010 Aug; 29(18):1947-57. PubMed ID: 20680987
[TBL] [Abstract][Full Text] [Related]
18. A generalized log-rank-type test for comparing survivals with doubly interval-censored data.
Kim J; Kim YJ; Nam CM
Biom J; 2009 Aug; 51(4):689-96. PubMed ID: 19650058
[TBL] [Abstract][Full Text] [Related]
19. A unified approach to power and sample size determination for log-rank tests under proportional and nonproportional hazards.
Tang Y
Stat Methods Med Res; 2021 May; 30(5):1211-1234. PubMed ID: 33819109
[TBL] [Abstract][Full Text] [Related]
20. Some permutation tests for survival data.
Sun Y; Sherman M
Biometrics; 1996 Mar; 52(1):87-97. PubMed ID: 8934586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
